Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexFemale
Age18-90
SponsorHelsinki University Central Hospital

About this trial

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

Eligibility criteria

Qualifiers

Female subjects aged ≥18

History of recurrent UTI: at least two episodes of UTI over the past 6 months or at least three episodes over the past year, most recent episode within the past three months

Written informed consent

Disqualifiers

Suspected non-compliance

Diagnosis of a gastrointestinal disease

Pregnancy

Immunosuppression

Trial design

Treatments tested in this trial

  • Feacal microbial transplantation (FMT)
  • Placebo transplantation (PT)

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Helsinki University Central Hospital

Lead sponsor

University of Helsinki

Collaborator